Publication

Article

CURE

Fall 2006
Volume5
Issue 4

The Scoring System

Researchers designed the Van Nuys Prognostic Index to aid in treatment decisions for women diagnosed with ductal carcinoma in situ, DCIS.

Introduced in 1996, researchers at the University of Southern California designed the Van Nuys Prognostic Index to aid in treatment decisions for women diagnosed with ductal carcinoma in situ. The original design combined DCIS size, margin width and pathologic classification, but in 2003, the patient’s age at diagnosis was added after it proved to be an independent prognostic factor.

Patients who are least likely to recur after recommended treatment have a score of 4, while patients most likely to recur receive a score of 12. Research has not yet been done to directly compare outcomes after mastectomy with those after lumpectomy for DCIS, but various studies show a clear reduction in local recurrence rates when comparing mastectomy with breast-conserving surgery. The lack of a significant survival difference when comparing those studies has led to fewer mastectomies.

View Chart: Treatment Guidelines by Score

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Related Content